Form D · Biotechnology
COH Inc.
San Diego, CA · CIK 0001509274
Offering snapshot reported Feb 2, 2012 · SEC filing
- Reported sold
- $10.1M Offering amount: $10.1M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 9, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,877,510 → $10,092,822
- Reported investors35 → 42
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 2, 2012 | Amendment | $10,092,822 | $5,215,312vs Dec 21, 2011 | 42 | SEC filing |
| Dec 21, 2011 | Initial | $4,877,510 | No comparison | 35 | SEC filing |
| Feb 28, 2011 | Amendment | $2,321,091 | $296,091vs Jan 18, 2011 | 25 | SEC filing |
| Jan 18, 2011 | Initial | $2,025,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170426
Source: Form D, filed Feb 2, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Frederick Finn | Director |
| La Don Johnson | Director, Executive, Promoter |
| Jean Pierre Nmn Lehmann | Director |
| Eugene Nmn Linden | Director |
| Rory Riggs | Director, Executive, Promoter |
| Richard Spizzirri | Director |
| John Abraham Studebaker | Director |
| Keith Walker | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6455 Nancy Ridge Drive Suite 100
San Diego, CA, 92121
San Diego, CA, 92121